Immunological features of Wegener's granulomatosis.
D000328:Adult; D000368:Aged; D001323:Autoantibodies / Q000032:analysis*; D001327:Autoimmune Diseases; D001379:Azathioprine / Q000627:therapeutic use; D001798:Blood Proteins / Q000032:analysis; D002464:Cell Migration Inhibition; D005260:Female; D005455:Fluorescent Antibody Technique; D005938:Glucocorticoids / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000097:blood / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D006801:Humans; D006968:Hypersensitivity, Delayed; D007105:Immune Complex Diseases / Q000150:complications; D007111:Immunity, Cellular; D005779:Immunodiffusion; D007136:Immunoglobulins / Q000032:analysis; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged
D001323:Autoantibodies; D001798:Blood Proteins; D005938:Glucocorticoids; D007136:Immunoglobulins; D001379:Azathioprine